A 27-year-old pregnant woman, 37 weeks pregnant, tested positive during antibody screening at Maternity and Child Healthcare Hospital. She had one child born by caesarian operation and no history of transfusions. She was referred to our blood center to reserve blood for caesarean operation. The blood groups of her and her husband are listed in Table 1 . At room temperature (RT), forward grouping was A 1 B group with D positive. Reverse grouping results were negative for A cells, weak agglutination (w ?) for B cells and 2 ? agglutination for O cells. Autocontrol and direct antiglobulin (IgG ? C3d) test were both negative. Antibody screening results of the commercially available panel (Sanquin, Makropanal 16, Lot: 8000236600) are showed in Table 1 . Further investigation revealed that by immediate spin, the antibody was strongly reactive against A 2 RBCs but not against O and B cord RBCs, suggesting that it is anti-IH. In order to identify whether the plasma contains other specific antibodies, we randomly selected five donors' RBCs for each blood group of A, B and AB respectively and reacted with plasma: group AB donors' RBCs were negative and group A and B donors' RBCs were consistent with the agglutination intensity seen in reverse grouping. We treated the patient's plasma with 2-mercaptoethanol (2-ME) and no agglutination was seen in panel cells with saline and antiglobulin media. Crossmatch tests with seven randomly chosen group AB units were compatible with saline and antiglobulin media. Fortunately, caesarean operation was successful without blood transfusion and the child was healthy.
Anti-IH sensitizes RBCs only in the presence of both H and I antigens together. It is usually observed in the serum of group A 1 B, A 1 , and B. Anti-IH is generally considered to be a harmless cold autoagglutinin. However, several literatures [1] [2] [3] [4] [5] Due to the close relationship of I to the biochemical structures of ABH, P, and Lewis antigens, one should not be surprised to find antibodies that recognize compound antigens.
In this case, the gravida's plasma was treated with 2-ME and no agglutination was found with panel cells with saline and antiglobulin media showed that only IgM antibodies were present. We accidentally found that the agglutination intensity of the plasma reacted with her husband's RBCs was stronger (2 ?) than reagent B cells at RT by immediate spin. Thus, we concluded that the plasma likely contained other low-incidence IgM antibodies. Regrettably, more samples were not available for further testing.
In summary, for patients with anti-IH, transfusions should use ABO-identical matched RBC units. Depending on electronic cross-match rather than conventional crossmatch could place the patient at risk of being transfused with other subgroups unless the antibody screening is strictly evaluated.
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